0R15 8108.0 0.02% 0R1E 7546.1929 0.315% 0M69 None None% 0R2V 169.25 -0.2946% 0QYR 1359.2961 0.1323% 0QYP 413.0 -0.7212% 0LCV None None% 0RUK None None% 0RYA 1740.0 -0.5714% 0RIH 154.3 -2.7112% 0RIH 155.8 0.9721% 0R1O 181.25 9872.4897% 0R1O None None% 0QFP None None% 0M2Z 304.8045 0.8869% 0VSO None None% 0R1I None None% 0QZI 502.0 -1.5686% 0QZ0 None None% 0NZF None None%
ADC Therapeutics SA
ADC Therapeutics SA is a clinical-stage cancer medication discovery and development business situated in Switzerland. It creates ADCs (antibody-drug conjugates) for the treatment of solid and hematological malignancies. To specifically target and destroy cancer cells, it uses monoclonal antibodies specific to certain tumor antigens coupled to PBD-based warheads. Multiple PBD-based ADCs are now in clinical studies, ranging from first-in-human to pivotal Phase II trials, and the company also has several preclinical ADCs in development.
Key Developments
Important financial highlights from Q1 FY22 Financial result
Stock Recommendation
ADCT's stock price has fallen 67.93% in the past six months and is currently leaning toward the lower end of its 52-week range of USD 6.18 to USD 32.
Given the stock's considerable bearish price movement over the past six months, financial results, and technical analysis, we propose a "Watch" rating on the stock at its closing price of USD 7.26, as of May 26, 2022, with a further analysis when ADCT breaks the range of USD 6.34 to USD 7.77.
1-Year Technical Chart, as of May 26, 2022. Data Source: REFINITIV, Analysis by Kalkine Group
Technical Analysis Summary
* Closing price as of May 26, 2022.
Investors can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario.
Technical Indicators Defined: -
Support: A level where-in the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest.
Resistance: A level where-in the stock prices tend to find resistance when they are rising, and the uptrend may take a pause due to profit booking or selling interest.
Stop-loss: It is a level to protect further losses in case of unfavorable movement in the stock prices.
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: Investment decisions should be made depending on the investors' appetite for upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting the stock if the Target Price mentioned as per the valuation has been achieved and subject to the factors discussed above.
Note 3: The report publishing date is as per the Pacific Time Zone.
Disclaimer
References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.
This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.
The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.
Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.
Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.